Detection and Identification of Candida auris from Clinical Skin Swabs

Milena Kordalewska1, David S Perlin2

  • 1Center for Discovery and Innovation, Hackensack Meridian Health, Nutley, NJ, USA. milena.kordalewska@hmh-cdi.org.

Insights

Rapidly detect Candida auris using a new real-time PCR assay. This method offers quick and accurate identification of the dangerous fungus directly from patient swabs, improving infection control.

Area of Science:

  • Medical Mycology
  • Infectious Diseases
  • Molecular Diagnostics

Background:

  • Candida auris is an emerging fungal pathogen causing significant nosocomial outbreaks globally.
  • Current diagnostic methods relying on yeast culture lead to delays of several days, hindering timely infection control.
  • Accurate and rapid detection is crucial for managing Candida auris in healthcare settings.

Purpose of the Study:

  • To develop and describe a real-time PCR assay for the direct detection and identification of Candida auris.
  • To provide a faster alternative to traditional culture-based diagnostic methods.

Main Methods:

  • Development of a real-time PCR protocol.
  • Application of the assay for direct detection from patient swab specimens.
  • Analysis of DNA extracted directly from clinical samples, bypassing the need for microbial culture.

Main Results:

  • The described real-time PCR assay enables rapid detection of Candida auris.
  • Accurate identification of the pathogen is achieved within hours, significantly reducing diagnostic time.
  • The protocol is suitable for direct application on patient swabs.

Conclusions:

  • This real-time PCR assay offers a rapid and accurate diagnostic solution for Candida auris.
  • The method facilitates timely implementation of infection prevention and control measures in healthcare facilities.
  • Direct nucleic acid-based detection bypasses culture limitations, addressing a critical need in clinical microbiology.

Related Concept Videos